(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ZISTORM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ZISTORM

ST13

US500000079235165

Class

5

Filing

79235165

Registration

5646017

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

03/26/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

04/25/2018

Registration date

01/08/2019

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/25/2025

Last transaction

03/26/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

CARDIFF, GB

Examiner

WIENER, MICHAEL

Law office

L80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Midatech Pharma (Wales) Limited

Representatives

Mewburn Ellis LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substances for the treatment of oncological and endocrine related diseases and disorders; all of the foregoing excluding pharmaceutical preparations and substances for the treatment of central nervous system diseases and disorderssleep disordersinsomnia and narcolepsyexcluding pharmaceutical preparations and substances for the treatment of neurological diseases or disorderssleep disordersinsomnia and narcolepsy

Publications

History of USPTO decisions and trademark events.

25 publications found

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

03/25/2026

C71T

CANCELLED SECTION 71

07/25/2025

GPNX

NOTIFICATION PROCESSED BY IB

03/08/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/16/2019

FIMP

FINAL DISPOSITION PROCESSED

02/16/2019

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

02/15/2019

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

02/08/2019

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

02/07/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

01/08/2019

CHPB

POST PUBLICATION AMENDMENT - ENTERED

11/30/2018

APET

ASSIGNED TO PETITION STAFF

11/29/2018

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

11/28/2018

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

11/14/2018

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

10/18/2018

GPNX

NOTIFICATION PROCESSED BY IB

09/21/2018

PUBO

PUBLISHED FOR OPPOSITION

09/18/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

09/05/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

09/05/2018

NPUB

NOTICE OF PUBLICATION

08/29/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/15/2018

DOCK

ASSIGNED TO EXAMINER

08/15/2018

MAFR

APPLICATION FILING RECEIPT MAILED

07/06/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/02/2018

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

06/28/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/28/2018

Continuous trademark protection

Get notified about every new filing that threatens ZISTORM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.